Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Blood (2022) 140 (Supplement 1): 121–123.

https://doi.org/10.1182/blood-2022-158934

Published: 2022

Journal Articles

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Daniel Heudobler, Sebastian Klobuch, MD, Florian Lüke, MD, Joachim Hahn, MD, Matthias Grube, MD, Stephan Kremers, MD, Thomas Südhoff, MD, Jörg Westermann, MD, Marie-Luise Huetter-Kroenke, MD, Peter Paschka, MD, Gauthier Bouche, Hartmut Döhner, MD, Wolfgang Herr, MD, Simone Thomas, MD, Albrecht Reichle, MD

Blood (2019) 134 (Supplement_1): 1382.

https://doi.org/10.1182/blood-2019-129977

Published: 2019

Journal Articles

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Tobias Boch, MD, Birgit Spiess, PhD, Oliver Cornely, MD, Werner J. Heinz, MD, Joachim Hahn, MD, Stefan W. Krause, MD, Hartmut Bertz, MD, Wolf-Karsten Hofmann, MD, Dieter Buchheidt, MD, Mark Reinwald, MD

Blood (2015) 126 (23): 2072.

https://doi.org/10.1182/blood.V126.23.2072.2072

Published: 2015

Journal Articles

Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome

Daniela Weber, Peter J. Oefner, Andreas Hiergeist, Josef Koestler, André Gessner, Markus Weber, Joachim Hahn, Daniel Wolff, Frank Stämmler, Rainer Spang, Wolfgang Herr, Katja Dettmer, Ernst Holler

Blood (2015) 126 (14): 1723–1728.

https://doi.org/10.1182/blood-2015-04-638858

Published: 2015

Includes: Supplemental data

Journal Articles

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Blood (2013) 122 (21): 4552.

https://doi.org/10.1182/blood.V122.21.4552.4552

Published: 2013

Journal Articles

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

Haefaa Alchalby, Anita Badbaran, Tatjana Zabelina, Guido Kobbe, Joachim Hahn, Daniel Wolff, Martin Bornhäuser, Christian Thiede, Herrad Baurmann, Wolfgang Bethge, York Hildebrandt, Ulrike Bacher, Boris Fehse, Axel R. Zander, Nicolaus Kröger

Blood (2010) 116 (18): 3572–3581.

https://doi.org/10.1182/blood-2009-12-260588

Published: 2010

Journal Articles

Compassionate Use of Combined Anti-Inflammatory and Angiostatic Treatment as Third-Line Therapy in Eight Patients with Multiple Myeloma – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan.

Albrecht Reichle, Martin Vogelhuber, Ernst Holler, PhD, Joachim Hahn, Reinhard Andreesen, MD, PhD

Blood (2009) 114 (22): 4958.

https://doi.org/10.1182/blood.V114.22.4958.4958

Published: 2009

Journal Articles

Severity of Chronic Gvhd and Personality Determines Quality of Life and the Activity Profile: Results of a Prospective German Multicenter Validation Trial

Daniel Wolff, MD, Philipp Herzberg, Pia Heussner, MD, Friederike Mumm, MD, Inken Hilgendorf, MD, Stephanie von Harsdorf, MD, Armin Gerbitz, MD, Hildegard T. Greinix, MD, Joachim Hahn, MD, Christian Junghanss, MD, Ernst Holler, PhD

Blood (2008) 112 (11): 742.

https://doi.org/10.1182/blood.V112.11.742.742

Published: 2008

Journal Articles

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies

Reinhard Marks, Karin Potthoff, Joachim Hahn, Gabriele Ihorst, Hartmut Bertz, Alexandros Spyridonidis, Ernst Holler, Jürgen M. Finke

Blood (2008) 112 (2): 415–425.

https://doi.org/10.1182/blood-2007-08-104745

Published: 2008

Journal Articles

Conditioning with Fludarabine, BCNU, and Melphalan in Allogeneic Stem Cell Transplantation Results in Reduced Toxixcity and High Activity Against Advanced Hematologic Malignancies.

Reinhard Marks, MD, Karin Potthoff, MD, Joachim Hahn, MD, Gabriele Ihorst, Hartmut Bertz, MD, Alexandros Spyridonidis, MD, Ernst Holler, MD, Jurgen Finke, MD

Blood (2007) 110 (11): 3066.

https://doi.org/10.1182/blood.V110.11.3066.3066

Published: 2007

Journal Articles

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Daniel Wolff, MD, Philipp Y. Herzberg, Pia Heussner, MD, Friederike Mumm, MD, Stephanie von Harsdorf, MD, Katrin Rieger, MD, Hildegard Greinix, Joachim Hahn, MD, Ernst Holler, Mathias Freund

Blood (2007) 110 (11): 42.

https://doi.org/10.1182/blood.V110.11.42.42

Published: 2007

Journal Articles

Highly Sensitive Real-Time PCR of V617F-JAK2-Mutation To Monitor Minimal Residual Disease and Guide Donor Lymphocte Infusion after Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Nicolaus Kroeger, MD, Anita Badbaran, Ernst Holler, MD, Joachim Hahn, MD, Guido Kobbe, MD, Martin Bornhauser, MD, Andreas Reiter, MD, Tatjana Zabelina, MD, Axel Zander, MD, Boris Fehse, MD

Blood (2006) 108 (11): 669.

https://doi.org/10.1182/blood.V108.11.669.669

Published: 2006

Journal Articles

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis

Nicolaus Kröger, Anita Badbaran, Ernst Holler, Joachim Hahn, Guido Kobbe, Martin Bornhäuser, Andreas Reiter, Tatjana Zabelina, Axel R. Zander, Boris Fehse

Blood (2006) 109 (3): 1316–1321.

https://doi.org/10.1182/blood-2006-08-039909

Published: 2006

Journal Articles

Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination

Ernst Holler, Gerhard Rogler, Julia Brenmoehl, Joachim Hahn, Hans Herfarth, Hildegard Greinix, Anne M. Dickinson, Gerard Socié, Daniel Wolff, Gottfried Fischer, Graham Jackson, Vanderson Rocha, Beate Steiner, Guenther Eissner, Jeorg Marienhagen, Juergen Schoelmerich, Reinhard Andreesen

Blood (2006) 107 (10): 4189–4193.

https://doi.org/10.1182/blood-2005-09-3741

Published: 2006

Journal Articles

PBSCT Similar to BMT Allows Active B-Lymphopoiesis Unless Severe GVHD Occurs.

Julia Winkler, MD, Armin Biller, MD, Natalie Schub, MD, Wolf Rösler, MD, Kerstin Eckart-Schäfer, MD, Hannes Wandt, MD, Claudia N. Kluender, MD, Rainer Schwerdtfeger, MD, Joachim Hahn, MD, Ernst Holler, MD, Thomas H. Winkler, PD, Martin Gramatzki, MD

Blood (2005) 106 (11): 5351.

https://doi.org/10.1182/blood.V106.11.5351.5351

Published: 2005

Journal Articles

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Ernst Holler, MD, PhD, Gerhard Rogler, MD, PhD, Joachim Hahn, MD, Hans Herfarth, MD, PhD, Julia Brenmoehl, Guenther Eissner, PhD, Anne M. Dickinson, PhD, Graham Jackson, MD, Hildegard Greinix, MD, PhD, Gerhard Fischer, MD, PhD, Daniel Wolff, MD, Beate Steiner, MD, Joerg Marienhagen, MD, PhD, Reinhard Andreesen, MD.PhD

Blood (2004) 104 (11): 424.

https://doi.org/10.1182/blood.V104.11.424.424

Published: 2004

Journal Articles

Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

Ernst Holler, Gerhard Rogler, Hans Herfarth, Julia Brenmoehl, Peter Johannes Wild, Joachim Hahn, Günther Eissner, Jürgen Schölmerich, Reinhard Andreesen

Blood (2004) 104 (3): 889–894.

https://doi.org/10.1182/blood-2003-10-3543

Published: 2004

NARROW

Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

Compassionate Use of Combined Anti-Inflammatory and Angiostatic Treatment as Third-Line Therapy in Eight Patients with Multiple Myeloma – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan.

Severity of Chronic Gvhd and Personality Determines Quality of Life and the Activity Profile: Results of a Prospective German Multicenter Validation Trial

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies

Conditioning with Fludarabine, BCNU, and Melphalan in Allogeneic Stem Cell Transplantation Results in Reduced Toxixcity and High Activity Against Advanced Hematologic Malignancies.

Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.

Highly Sensitive Real-Time PCR of V617F-JAK2-Mutation To Monitor Minimal Residual Disease and Guide Donor Lymphocte Infusion after Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis

Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination

PBSCT Similar to BMT Allows Active B-Lymphopoiesis Unless Severe GVHD Occurs.

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only